David A. Siegel Stereotaxis, Inc. Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 171,600 shares of STXS stock, worth $379,236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,600Holding current value
$379,236% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding STXS
# of Institutions
100Shares Held
42.8MCall Options Held
10.1KPut Options Held
11.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...